# Leadership, Planning, and Evaluation

> **NIH NIH P30** · INDIANA UNIVERSITY INDIANAPOLIS · 2021 · $501,296

## Abstract

ABSTRACT, Leadership, Planning and Evaluation 
The Indiana University Melvin and Bren Simon Cancer Center (IUSCC) has established an effective process for 
Leadership, Planning and Evaluation that receives input from its Senior Leaders, Program Leaders and 
Membership as well as internal and external advisory committees. Based on this input, the IUSCC leadership 
has molded its strategic plan, implemented this plan, and regularly evaluates its impact on its four Research 
Programs and multiple Shared Resources (Cores) advancing our mission to serve the citizens of Indiana and 
beyond. The IUSCC Strategic Plan, which was updated in 2018, has four major research pillars: Biology to 
Bedside Translational Research, Precision Medicine , Population Health (with an emphasis on Prevention, Early 
Detection and Health Care Disparities), and Survivorship and Symptom Science. Following this strategic plan 
and with feedback from our advisors, the Senior Leadership implemented a number of actions during the last 
funding period including: 1) dissolving the Breast Cancer Program and integrated its members into the remaining 
basic and translational research programs; 2) appointing an Associate Dean of Translational Research; 3) 
installing new leadership in the Cancer Prevention and Control (CPC) and the Experimental and Developmental 
Therapeutics (EDT) Programs; 4) renaming Hematopoiesis, Hematologic Malignancies and Immunology (HMI) 
Program to Hematopoiesis and Hematologic Malignancies (HHM) to emphasize its focus on “liquid tumors” and 
recognizing that cancer immunology cuts across all programs; 5) creating the Office of Community Outreach 
and Engagement to drive our activities throughout the state; 6) formally establishing the Tumor Microenvironment 
and Metastasis (TMM) and HHM programs as basic research programs; 7) developed new Cancer 
Bioinformatics and Translational Research cores; and 8) integrated the IUSM's Proteomics and Genomics Cores 
with the IUSCC. These changes, informed by the thematic pillars of our strategic plan, drive the IUSCC's mission 
to impact research, patient care and education both locally and globally by bolstering team science, amplifying 
community outreach and engagement activities and expanding our educational footprint to inspire the next 
generation of cancer researchers.

## Key facts

- **NIH application ID:** 10247621
- **Project number:** 5P30CA082709-22
- **Recipient organization:** INDIANA UNIVERSITY INDIANAPOLIS
- **Principal Investigator:** PATRICK J. LOEHRER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $501,296
- **Award type:** 5
- **Project period:** 1999-09-22 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10247621

## Citation

> US National Institutes of Health, RePORTER application 10247621, Leadership, Planning, and Evaluation (5P30CA082709-22). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10247621. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*